Hamilton Pharmaceuticals Inc.
This article was originally published in Start Up
Executive Summary
Thomas N. Chase, MD, had a prolific career as an investigator at the National Institutes of Neurological Disorders and Stroke. Now at specialty pharma start-up Hamilton Pharmaceuticals Inc., Chase plans to build a pipeline of drugs for a full spectrum of CNS disorders, including stroke, Parkinson's disease, epilepsy, multiple sclerosis and schizophrenia.